Categories: News

BioCryst to Present at 2021 Cantor Virtual Healthcare Conference

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

RESEARCH TRIANGLE PARK, N.C., Sept. 21, 2021 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the company will present at the 2021 Cantor Virtual Healthcare Conference on Tuesday, September 28, 2021 at 2:00 p.m. ET.

Links to a live audio webcast and replay of this presentation may be accessed in the Investors section of BioCryst’s website at http://www.biocryst.com.

About BioCryst Pharmaceuticals

BioCryst Pharmaceuticals discovers novel, oral, small-molecule medicines that treat rare diseases in which significant unmet medical needs exist and an enzyme plays a key role in the biological pathway of the disease. Oral, once-daily ORLADEYO® (berotralstat) is approved in the United States, the European Union, Japan, the United Kingdom and the United Arab Emirates. BioCryst has several ongoing development programs including BCX9930, an oral Factor D inhibitor for the treatment of complement-mediated diseases, BCX9250, an ALK-2 inhibitor for the treatment of fibrodysplasia ossificans progressiva, and galidesivir, a potential treatment for Marburg virus disease and Yellow Fever. RAPIVAB® (peramivir injection) has received regulatory approval in the U.S., Canada, Australia, Japan, Taiwan and Korea. Post-marketing commitments for RAPIVAB are ongoing. For more information, please visit the company’s website at www.biocryst.com.

BCRXW

Investors:
John Bluth
+1 919 859 7910
jbluth@biocryst.com

Media:
Catherine Collier Kyroulis
+1 917 886 5586
ckyroulis@biocryst.com

Staff

Recent Posts

FendX Engages Branding Expert to Support Branding and Marketing for Its Planned Eco-Friendly Sponge Products

Oakville, Ontario--(Newsfile Corp. - June 11, 2025) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF)…

27 minutes ago

London College of Contemporary Arts Launches Free Mental Health and Wellness Support for Students and Staff

Global mental health and wellness solution leader Uwill accelerates international expansion with fifth UK partnership…

27 minutes ago

P2P Group Increases Biometric Detection Range by 166%–Transforming Security, Defence and Aged Care

(CSE: PPB / FSE: 3QG / US: PPBGF)investor@p2p-group.com Highlights: Opens new markets in border control,…

28 minutes ago

Strategikon Pharma Secures Growth Loan to Expand Sales and Client Support Teams Amid Rising Demand

Company-friendly debt solution will support expansion of the rapidly-growing innovative software company SAN FRANCISCO, June…

6 hours ago

lllumina releases 2024 Corporate Social Responsibility Report as it advances its vision to unlock the power of genomics

SAN DIEGO, June 10, 2025 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), aligned with its commitments…

12 hours ago

Applied Medical Technology, Inc. Unveils Redesigned Mobile App Aligned with Recent Website Refresh

BRECKSVILLE, Ohio., June 10, 2025 /PRNewswire/ -- Applied Medical Technology, Inc. (AMT), a leader in innovative…

12 hours ago